• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS25
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Complete Heart Block (2627)
Event Date 06/27/2019
Event Type  Injury  
Manufacturer Narrative
Since the serial number of the involved device is unknown and given that the device was not explanted, no device investigation can be performed at this time.As such, a definitive root cause of the reported event cannot be determined at this time.Conduction disorders are common in patients with aortic valve diseases.As a result, it is common for patients to receive permanent pacemaker implantation after aortic valve replacement.Risk factors include preexisting conducting disease and preoperative aortic regurgitation.This event is, therefore, a known, inherent risk of the procedure, and it is listed among the potential adverse events in the perceval ifu.The manufacturer has made an inquiry to retrieve the serial number of the device.If received, proper investigative actions will be taken and a follow up report will be submitted.Device not explanted.
 
Event Description
The manufacturer was informed on this event through the sure avr study.On (b)(6) 2019, a patient received a pvs25 in aortic position.Sizing difficulties occurred during the procedure, specified as an imperfect alignment along the non-coronary sinus.The procedure was performed in mini-thoracotomy.On (b)(6) 2019, the site reports that the patient received a permanent pacemaker due to an atrioventricular block grade iii, defined as a new conduction abnormality for this patient.Pre-operatively, the patient was in regular sinus rhythm.The patient was discharged to a rehabilitation clinic on (b)(6) 2019.
 
Manufacturer Narrative
The manufacturer has updated the initial reporter information with the proper contact information.The remainder of the information previously submitted remains unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key9420534
MDR Text Key169611501
Report Number3004478276-2019-00327
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 01/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/07/2019
Initial Date FDA Received12/05/2019
Supplement Dates Manufacturer Received01/10/2020
Supplement Dates FDA Received01/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
Patient Weight82
-
-